Brief: Purapharm Corp Says Cheong Shin Keong Will Be Re-Designed AS Executive Director
25/08/2020 16:01
Aug 25 (Reuters) - PuraPharm Corp Ltd 1498.HK :
* CHEONG SHIN KEONG WILL BE RE-DESIGNED FROM A NON-EXECUTIVE
DIRECTOR TO AN EXECUTIVE DIRECTOR
* CHAN KIN MAN EDDIE WILL BE RE- DESIGNED FROM AN EXECUTIVE
DIRECTOR TO A NON-EXECUTIVE DIRECTOR
Source text for Eikon: ID:nHKS7FJFDn
Further company coverage: 1498.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PuraPharm
See all newsBrief: Purapharm Corp To Issue Convertible Bonds With Principal Amount Of HK$20 MLN
Brief: Purapharm Corp To Issue Consideration Shares As Licence Fee
Brief: Purapharm Says Kam Biu Tsoi, Alvin Appointed As Executive Director
Brief: Purapharm Corp Announces Lapse Of Disposal Agreement
Brief: PuraPharm Corp To Dispose Of Accounts Receivables At HK$15 Mln